StockData
DBV Technologies S.A. logo

DBV Technologies S.A. (DBVT) income statement

DBVTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as DBVTF
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 6/30
$9.99−0.28 (-2.73%)

Close on Nov 17, 2026Market cap $628.15MP/E –Yield –

DBV Technologies S.A. income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
–
Operating margin
-5431.6%
Net margin
-5405.3%
Return on equity, FY2025
-149.8%

Financial strength

Current ratio
3.24
Debt to equity
–
Debt to assets
–
Cash to current liabilities
283.2%

Valuation

P/E ratio
–
Price to sales
163.75
Price to book
4.23
Dividend yield
–

See a number that looks wrong?